Buy
Sell
Share Name Share Symbol Market Type
OPTIBIOTIX HEALTH PLC NEX:OPTI.GB NEX Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.83p -2.04% 87.67p 87.00p 0.00p 89.50p 85.00p 89.50p 37,438 16:25:52

OptiBiotix Health PLC Notice of AGM

17/05/2019 7:00am

UK Regulatory (RNS & others)


OPTIBIOTIX HEALTH (NEX:OPTI.GB)
Historical Stock Chart

1 Month : From Apr 2019 to May 2019

Click Here for more OPTIBIOTIX HEALTH Charts.

TIDMOPTI

RNS Number : 3230Z

OptiBiotix Health PLC

17 May 2019

OptiBiotix Health plc

("OptiBiotix" or the "Company")

Notice of AGM

OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces the Annual General Meeting will be held on 11 June 2019 at 3pm at Foxhills Country Club, Stonehill Road, Ottershaw, Surrey KT16 0EL.

A copy of the notice of AGM will be available on the Company's website today.

For further information, please contact:

 
 OptiBiotix Health plc                                             www.optibiotix.com 
 Stephen O'Hara, Chief Executive                                 Contact via Walbrook 
                                                                                below 
 
 Cairn Financial Advisers LLP (NOMAD)                              Tel: 020 7213 0880 
 Liam Murray / Jo Turner 
 
   finnCap (Broker)                                                Tel: 020 7220 0500 
 Geoff Nash / Kate Bannatyne (Corporate Finance) 
 Camille Gochez (Corporate Broking) 
 
 Walbrook PR Ltd                      Tel: 020 7933 8780 or optibiotix@walbrookpr.com 
 Anna Dunphy                                                       Mob: 07876 741 001 
 
 

About OptiBiotix - www.optibiotix.com

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome - the collective genome of the microbes in the body - in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products. The Company's current areas of focus include obesity, cardiovascular health, and diabetes.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NOAAFMATMBTBBML

(END) Dow Jones Newswires

May 17, 2019 02:00 ET (06:00 GMT)

1 Year OPTIBIOTIX HEALTH Chart

1 Year OPTIBIOTIX HEALTH Chart

1 Month OPTIBIOTIX HEALTH Chart

1 Month OPTIBIOTIX HEALTH Chart
Your Recent History
NEX
OPTI.GB
OPTIBIOTIX..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190522 22:56:19